Industry: Health care Region: European Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A European eye cleaning product R&D and manufacturing enterprise has been established for more than 30 years, focusing on the application of biocompatible materials and eco-friendly technologies for a long time.
The core products are all based on natural plant extracts, and do not contain preservatives and other additives. Thirteen product lines have been built, including atomized drug delivery system, targeted artificial tears, special series for women and infants, and inflammation and dry eye treatment products, covering more than 40 countries and regions around the world.
Cooperation mode:
Enterprises are now seeking financing to expand the China market, and it is planned to land in the form of channel cooperation, CDMO contract R&D and production or technical authorization.